We observed a significant increase in serpinA3 mRNA levels starting at the 3rd month post-ischemia compared to the control group (Fig. 3A); however, this difference was not reflected at the protein level, as is shown by the Western blot analysis, in which no differences between groups were observed (Fig. 3B). The gene discussed is SERPINA3; the disease is ischemia.